Perkins James J, Shurtleff Valerie W, Johnson Alayna M, El Marrouni Abdellatif
Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States.
ACS Med Chem Lett. 2021 Mar 8;12(4):662-666. doi: 10.1021/acsmedchemlett.0c00673. eCollection 2021 Apr 8.
Nucleoside analogues have been and continue to be extremely important compounds in drug discovery. Despite the significant effort dedicated to their synthesis, medicinal chemistry campaigns around these structures are often hampered by synthetic challenges. We describe a strategy for the functionalization of purine nucleosides via photoredox and nickel-catalyzed sp-sp cross-coupling. The conditions described herein allow for coupling of unprotected nucleosides with readily available alkyl bromides, providing opportunities for their application to parallel medicinal chemistry.
核苷类似物一直是且仍然是药物研发中极其重要的化合物。尽管在其合成方面投入了大量精力,但围绕这些结构开展的药物化学研究常常受到合成难题的阻碍。我们描述了一种通过光氧化还原和镍催化的sp-sp交叉偶联对嘌呤核苷进行官能化的策略。本文所述的条件允许未保护的核苷与易于获得的烷基溴化物进行偶联,为其在平行药物化学中的应用提供了机会。